Free Trial

Avantor, Inc. (NYSE:AVTR) Receives $25.50 Average PT from Analysts

Avantor logo with Medical background
Remove Ads

Shares of Avantor, Inc. (NYSE:AVTR - Get Free Report) have been assigned an average rating of "Moderate Buy" from the thirteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 1-year price target among analysts that have covered the stock in the last year is $25.50.

AVTR has been the subject of several research reports. Stifel Nicolaus lowered their price objective on shares of Avantor from $28.00 to $26.00 and set a "buy" rating for the company in a research report on Monday, February 10th. Royal Bank of Canada lowered their price target on shares of Avantor from $33.00 to $31.00 and set an "outperform" rating for the company in a report on Monday, February 10th. Morgan Stanley decreased their price objective on Avantor from $27.00 to $25.00 and set an "overweight" rating on the stock in a research report on Monday, February 10th. Wells Fargo & Company cut their price target on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Finally, Citigroup dropped their price objective on Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a report on Tuesday, March 4th.

Get Our Latest Research Report on Avantor

Avantor Price Performance

Shares of NYSE:AVTR traded up $1.65 during trading on Friday, reaching $15.93. The stock had a trading volume of 15,171,297 shares, compared to its average volume of 6,742,524. The stock has a market capitalization of $10.85 billion, a PE ratio of 15.32, a P/E/G ratio of 1.55 and a beta of 1.24. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. Avantor has a 52 week low of $13.82 and a 52 week high of $28.00. The business's 50-day moving average price is $17.08 and its 200 day moving average price is $20.63.

Remove Ads

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the prior year, the business posted $0.22 earnings per share. As a group, equities analysts predict that Avantor will post 1.06 earnings per share for the current year.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 4,907 shares of the stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the sale, the chief accounting officer now directly owns 40,604 shares in the company, valued at $711,788.12. This represents a 10.78 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP James Bramwell sold 3,758 shares of Avantor stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares in the company, valued at $1,531,753.87. This trade represents a 4.12 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company's stock.

Institutional Investors Weigh In On Avantor

Several large investors have recently made changes to their positions in AVTR. Cerity Partners LLC boosted its stake in Avantor by 122.6% in the 3rd quarter. Cerity Partners LLC now owns 30,538 shares of the company's stock worth $790,000 after purchasing an additional 16,818 shares during the period. Bank of Montreal Can acquired a new position in shares of Avantor during the third quarter worth about $2,575,000. Captrust Financial Advisors boosted its position in shares of Avantor by 26.4% during the third quarter. Captrust Financial Advisors now owns 17,852 shares of the company's stock worth $462,000 after buying an additional 3,733 shares during the period. Investment Management Corp of Ontario grew its holdings in shares of Avantor by 49.7% during the third quarter. Investment Management Corp of Ontario now owns 22,585 shares of the company's stock worth $584,000 after buying an additional 7,500 shares in the last quarter. Finally, Royal London Asset Management Ltd. raised its position in Avantor by 1.8% in the 3rd quarter. Royal London Asset Management Ltd. now owns 254,888 shares of the company's stock valued at $6,594,000 after buying an additional 4,580 shares during the last quarter. Institutional investors own 95.08% of the company's stock.

Avantor Company Profile

(Get Free Report

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Stories

Analyst Recommendations for Avantor (NYSE:AVTR)

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads